TrakCel

Founded in 2012, TrakCel has established itself as a key enabler in the complex cell and gene therapy (CGT) sector by developing digital orchestration platforms. Its second-generation OCELLOS platform addresses critical challenges in the CGT supply chain, such as chain of identity/custody, logistics coordination, and integration between clinical sites, manufacturers, and logistics providers. The company serves therapy developers from clinical trials through commercialization, positioning itself as a vital infrastructure partner in a high-growth, innovative field. TrakCel's business model is built on its software platform and complementary professional services, backed by industry experts.

OCELLOS, a second-generation, modular, Salesforce-powered cellular orchestration platform for tracking and managing the supply chain of cell and gene therapies. It provides end-to-end visibility, integrates with logistics and manufacturing systems, and ensures regulatory compliance with full audit trails.

TrakCel competes in the niche market of cell and gene therapy supply chain orchestration software. Competitors include other specialized software providers (e.g., Vineti, SAP's dedicated solutions), broader supply chain management platforms adapting to life sciences, and custom in-house systems built by large pharmaceutical companies. TrakCel differentiates through its deep domain focus, Salesforce-based architecture for flexibility, and integrated professional services.